FAQ
Log In
Tuesday 6th December 2016
News
 › 
 › 

Birmingham uses OMNI-Lab

10th September 2009

A subset of OMNI-Lab is being used by Birmingham Children’s Hospital NHS Foundation Trust to manage the bloodspot screening tests taken from 70,000 newborn infants across the West Midlands each year.

The heelprick tests can screen for five serious diseases, as part of the UK Newborn Screening Programme, which is carried out by centres of excellence across the UK. Great Ormond Street Children’s Hospital is already using OMNI-Lab NewBorn Screening to manage the process from receipt of blood spot card to results and statistical reporting.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2016